Less paperwork, more investment urged at Capitol Hill 'cures' roundtable
This article was originally published in Scrip
Executive Summary
In what was being hailed as a "unique" moment on Capitol Hill on 6 May, about a dozen lawmakers sat down with 11 of the top scientific, regulatory and investment leaders in the US to discuss better ways to drive the acceleration of discovery, development and delivery processes for new medicines.